Literature DB >> 20215116

Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1).

Miguel Sánchez-Álvarez1, Marta Montes2, Noemí Sánchez-Hernández2, Cristina Hernández-Munain3, Carlos Suñé4.   

Abstract

Modification of proteins by small ubiquitin-like modifier (SUMO) is emerging as an important control of transcription and RNA processing. The human factor TCERG1 (also known as CA150) participates in transcriptional elongation and alternative splicing of pre-mRNAs. Here, we report that SUMO family proteins modify TCERG1. Furthermore, TCERG1 binds to the E2 SUMO-conjugating enzyme Ubc9. Two lysines (Lys-503 and Lys-608) of TCERG1 are the major sumoylation sites. Sumoylation does not affect localization of TCERG1 to the splicing factor-rich nuclear speckles or the alternative splicing function of TCERG1. However, mutation of the SUMO acceptor lysine residues enhanced TCERG1 transcriptional activity, indicating that SUMO modification negatively regulates TCERG1 transcriptional activity. These results reveal a regulatory role for sumoylation in controlling the activity of a transcription factor that modulates RNA polymerase II elongation and mRNA alternative processing, which are discriminated differently by this post-translational modification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215116      PMCID: PMC2865347          DOI: 10.1074/jbc.M109.063750

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo.

Authors:  T Misteli; D L Spector
Journal:  Mol Cell       Date:  1999-06       Impact factor: 17.970

2.  The splicing factor, Prp40, binds the phosphorylated carboxyl-terminal domain of RNA polymerase II.

Authors:  D P Morris; A L Greenleaf
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

Review 3.  SUMO: a history of modification.

Authors:  Ronald T Hay
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

4.  SUMO-1 modification alters ADAR1 editing activity.

Authors:  Joana M P Desterro; Liam P Keegan; Ellis Jaffray; Ron T Hay; Mary A O'Connell; Maria Carmo-Fonseca
Journal:  Mol Biol Cell       Date:  2005-08-24       Impact factor: 4.138

5.  The human SWI/SNF subunit Brm is a regulator of alternative splicing.

Authors:  Eric Batsché; Moshe Yaniv; Christian Muchardt
Journal:  Nat Struct Mol Biol       Date:  2005-12-11       Impact factor: 15.369

Review 6.  Something about SUMO inhibits transcription.

Authors:  Grace Gill
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

7.  Repression of SOX6 transcriptional activity by SUMO modification.

Authors:  R Fernández-Lloris; N Osses; E Jaffray; L N Shen; O A Vaughan; D Girwood; R Bartrons; J L Rosa; R T Hay; F Ventura
Journal:  FEBS Lett       Date:  2006-01-20       Impact factor: 4.124

Review 8.  Promoter usage and alternative splicing.

Authors:  Alberto R Kornblihtt
Journal:  Curr Opin Cell Biol       Date:  2005-06       Impact factor: 8.382

9.  SUMO-1 modification of human transcription factor (TF) IID complex subunits: inhibition of TFIID promoter-binding activity through SUMO-1 modification of hsTAF5.

Authors:  Michaël Boyer-Guittaut; Kivanç Birsoy; Corinne Potel; Gill Elliott; Ellis Jaffray; Joanna M Desterro; Ron T Hay; Thomas Oelgeschläger
Journal:  J Biol Chem       Date:  2005-01-06       Impact factor: 5.157

10.  Differential recruitment of pre-mRNA splicing factors to alternatively spliced transcripts in vivo.

Authors:  Stephen A Mabon; Tom Misteli
Journal:  PLoS Biol       Date:  2005-10-25       Impact factor: 8.029

View more
  13 in total

1.  TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.

Authors:  Marta Montes; Alexandre Cloutier; Noemí Sánchez-Hernández; Laetitia Michelle; Bruno Lemieux; Marco Blanchette; Cristina Hernández-Munain; Benoit Chabot; Carlos Suñé
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

2.  Transcriptional Elongation Regulator 1 Affects Transcription and Splicing of Genes Associated with Cellular Morphology and Cytoskeleton Dynamics and Is Required for Neurite Outgrowth in Neuroblastoma Cells and Primary Neuronal Cultures.

Authors:  Juan Pablo Muñoz-Cobo; Noemí Sánchez-Hernández; Sara Gutiérrez; Younes El Yousfi; Marta Montes; Carme Gallego; Cristina Hernández-Munain; Carlos Suñé
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

3.  The FF4 and FF5 domains of transcription elongation regulator 1 (TCERG1) target proteins to the periphery of speckles.

Authors:  Noemí Sánchez-Hernández; Lidia Ruiz; Miguel Sánchez-Álvarez; Marta Montes; Maria J Macias; Cristina Hernández-Munain; Carlos Suñé
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

Review 4.  Roles for SUMO in pre-mRNA processing.

Authors:  Patrick K Nuro-Gyina; Jeffrey D Parvin
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-11-13       Impact factor: 9.957

5.  Prp40 pre-mRNA processing factor 40 homolog B (PRPF40B) associates with SF1 and U2AF65 and modulates alternative pre-mRNA splicing in vivo.

Authors:  Soraya Becerra; Marta Montes; Cristina Hernández-Munain; Carlos Suñé
Journal:  RNA       Date:  2015-01-20       Impact factor: 4.942

6.  Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing.

Authors:  Marta Montes; Mayte Coiras; Soraya Becerra; Cristina Moreno-Castro; Elena Mateos; Jara Majuelos; F Javier Oliver; Cristina Hernández-Munain; José Alcamí; Carlos Suñé
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

7.  The in vivo dynamics of TCERG1, a factor that couples transcriptional elongation with splicing.

Authors:  Noemí Sánchez-Hernández; Stéphanie Boireau; Ute Schmidt; Juan Pablo Muñoz-Cobo; Cristina Hernández-Munain; Edouard Bertrand; Carlos Suñé
Journal:  RNA       Date:  2016-02-12       Impact factor: 4.942

8.  Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy.

Authors:  Marc Suñé-Pou; Silvia Prieto-Sánchez; Younes El Yousfi; Sofía Boyero-Corral; Anna Nardi-Ricart; Isaac Nofrerias-Roig; Pilar Pérez-Lozano; Encarna García-Montoya; Montserrat Miñarro-Carmona; Josep Ramón Ticó; Josep Mª Suñé-Negre; Cristina Hernández-Munain; Carlos Suñé
Journal:  Int J Nanomedicine       Date:  2018-05-30

9.  Spatiotemporal distribution of small ubiquitin-like modifiers during human placental development and in response to oxidative and inflammatory stress.

Authors:  Dora Baczyk; Melanie C Audette; Etienne Coyaud; Brian Raught; John C Kingdom
Journal:  J Physiol       Date:  2018-04-06       Impact factor: 5.182

Review 10.  Nuclear speckles: molecular organization, biological function and role in disease.

Authors:  Lukasz Galganski; Martyna O Urbanek; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2017-10-13       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.